STOCK TITAN

Therma Bright Inc. Announces Share Consolidation

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Neutral)
Tags
Therma Bright Inc. (TBRIF) has announced plans for an 8:1 share consolidation, pending TSX Venture Exchange approval. The consolidation will reduce the company's outstanding shares from 451,632,147 to approximately 56,454,018 shares. This strategic move aims to provide increased flexibility for future financings and business transactions. The consolidation will also proportionally adjust outstanding options, warrants, and other rights to acquire common shares. The Board of Directors approved this action under the company's Articles of Incorporation, which allows for consolidations up to 10:1 without shareholder approval. Therma Bright confirms this is their only consolidation in the past 24 months, complying with TSXV Policy 5.8.
Therma Bright Inc. (TBRIF) ha annunciato piani per una consolidazione azionaria 8:1, in attesa dell'approvazione della TSX Venture Exchange. La consolidazione ridurrà le azioni in circolazione da 451.632.147 a circa 56.454.018 azioni. Questa mossa strategica mira a offrire maggiore flessibilità per futuri finanziamenti e operazioni commerciali. La consolidazione adeguerà proporzionalmente anche le opzioni, i warrant e altri diritti di acquisizione di azioni ordinarie in essere. Il Consiglio di Amministrazione ha approvato questa azione ai sensi dello Statuto della società, che consente consolidamenti fino a 10:1 senza l'approvazione degli azionisti. Therma Bright conferma che questa è l'unica consolidazione negli ultimi 24 mesi, in conformità con la Politica 5.8 della TSXV.
Therma Bright Inc. (TBRIF) ha anunciado planes para una consolidación de acciones 8:1, pendiente de la aprobación de la TSX Venture Exchange. La consolidación reducirá las acciones en circulación de 451,632,147 a aproximadamente 56,454,018 acciones. Esta medida estratégica busca proporcionar mayor flexibilidad para futuros financiamientos y transacciones comerciales. La consolidación también ajustará proporcionalmente las opciones, warrants y otros derechos para adquirir acciones comunes vigentes. La Junta Directiva aprobó esta acción bajo los Estatutos de la empresa, que permiten consolidaciones de hasta 10:1 sin necesidad de aprobación de los accionistas. Therma Bright confirma que esta es su única consolidación en los últimos 24 meses, cumpliendo con la Política 5.8 de TSXV.
Therma Bright Inc.(TBRIF)는 TSX 벤처 거래소의 승인을 기다리며 8:1 주식 병합 계획을 발표했습니다. 이번 병합으로 회사의 발행 주식 수는 451,632,147주에서 약 56,454,018주로 줄어들게 됩니다. 이 전략적 조치는 향후 자금 조달 및 사업 거래에 대한 유연성을 높이기 위한 것입니다. 병합은 또한 기존의 주식 매수선택권, 워런트 및 기타 보통주 취득 권리도 비례하여 조정됩니다. 이사회는 주주 승인 없이 최대 10:1 병합을 허용하는 회사 정관에 따라 이 조치를 승인했습니다. Therma Bright는 지난 24개월 동안 이 병합이 유일한 병합임을 확인하며 TSXV 정책 5.8을 준수하고 있음을 밝혔습니다.
Therma Bright Inc. (TBRIF) a annoncé un projet de regroupement d’actions au ratio de 8 pour 1, sous réserve de l’approbation de la TSX Venture Exchange. Cette opération réduira le nombre d’actions en circulation de 451 632 147 à environ 56 454 018 actions. Cette initiative stratégique vise à offrir une plus grande flexibilité pour les futurs financements et transactions commerciales. Le regroupement ajustera également proportionnellement les options, bons de souscription et autres droits d’acquisition d’actions ordinaires en circulation. Le conseil d’administration a approuvé cette mesure conformément aux statuts de la société, qui autorisent des regroupements jusqu’à 10 pour 1 sans approbation des actionnaires. Therma Bright confirme qu’il s’agit de son unique regroupement au cours des 24 derniers mois, respectant ainsi la politique 5.8 de la TSXV.
Therma Bright Inc. (TBRIF) hat Pläne für eine 8:1-Aktiensplit-Anpassung angekündigt, vorbehaltlich der Genehmigung der TSX Venture Exchange. Die Konsolidierung wird die ausstehenden Aktien von 451.632.147 auf etwa 56.454.018 Aktien reduzieren. Dieser strategische Schritt soll mehr Flexibilität für zukünftige Finanzierungen und Geschäftstransaktionen bieten. Die Konsolidierung wird auch die ausstehenden Optionen, Warrants und andere Rechte zum Erwerb von Stammaktien anteilig anpassen. Der Vorstand genehmigte diese Maßnahme gemäß der Satzung des Unternehmens, die Konsolidierungen bis zu 10:1 ohne Zustimmung der Aktionäre erlaubt. Therma Bright bestätigt, dass dies die einzige Konsolidierung in den letzten 24 Monaten ist und somit die TSXV-Richtlinie 5.8 eingehalten wird.
Positive
  • Consolidation provides increased flexibility for future financings and business transactions
  • Board has authority to execute consolidation without requiring shareholder approval, streamlining the process
Negative
  • Significant share reduction may impact trading liquidity
  • Smaller shareholders with less than 4 shares will lose their holdings due to rounding down

Toronto, Ontario--(Newsfile Corp. - June 11, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma Bright" or the "Company"), a developer and investment partner specializing in advanced diagnostic and medical device technologies, announces, subject to the approval of the TSX Venture Exchange (the "TSXV"), that it will be undertaking a consolidation (the "Consolidation") of its common shares on the basis of eight (8) pre-Consolidation common shares for one (1) post-Consolidation common share. The Company expects that the Consolidation will provide the Company with increased flexibility in structuring and completing financings and potential business transactions.

No fractional common shares will be issued, and fractions of less than one-half of a share will be cancelled and fractions of at least one-half of a share will be converted to a whole common share. Outstanding options, warrants and other rights to acquire common shares will likewise be adjusted for the Consolidation.

The Company currently has 451,632,147 common shares outstanding and accordingly expects 56,454,018 common shares to be outstanding on completion of the Consolidation (subject to rounding adjustments and any further share issuances prior to the Consolidation). The Company does not expect to change its name or trading symbol in conjunction with the Consolidation.

The Consolidation has been approved by the Board of Directors pursuant to the Company's Articles of Incorporation, which empowers the Board to effect share consolidations of up to 10:1 without shareholder approval. The Company confirms that this is the only share consolidation conducted within the past 24 months and the cumulative consolidation ratio does not exceed 10:1, in compliance with TSXV Policy 5.8.

About Therma Bright Inc.

Therma Bright develops and partners on cutting-edge diagnostic and medical device technologies that address key healthcare challenges. Therma Bright Inc. trades on the (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX). Visit: www.thermabright.com.

Therma Bright Inc.
Rob Fia, CEO
rfia@thermabright.com

Follow us on X

FORWARD-LOOKING STATEMENTS

Certain statements in this news release constitute "forward-looking" statements. These statements relate to future events such as current and future development of Therma Bright's products and related technology as described in the news release. All such statements involve substantial known and unknown risks, uncertainties and other factors which may cause the actual results to vary from those expressed or implied by such forward-looking statements. Forward-looking statements involve significant risks and uncertainties, they should not be read as guarantees of future performance or results, and they will not necessarily be accurate indications of whether such results will be achieved. Actual results could differ materially from those anticipated due to several factors and risks. Although the forward-looking statements contained in this news release are based upon what management of the Company believes are reasonable assumptions on the date of this news release, the Company cannot assure investors that actual results will be consistent with these forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof and the Company disclaims any intention or obligation to update or revise any forward-looking statements whether because of new information, future events or otherwise, except as required under applicable securities regulations. Completion of the Consolidation remains subject to all necessary corporate and regulatory approvals. If the required approvals are not obtained, the Consolidation may not proceed as contemplated or at all.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/255196

FAQ

What is the share consolidation ratio announced by Therma Bright (TBRIF)?

Therma Bright announced an 8:1 share consolidation ratio, meaning every 8 pre-consolidation shares will be converted into 1 post-consolidation share.

How many shares will Therma Bright (TBRIF) have after the consolidation?

After the consolidation, Therma Bright expects to have approximately 56,454,018 common shares outstanding, reduced from 451,632,147 shares.

Will Therma Bright (TBRIF) change its name or trading symbol after the consolidation?

No, Therma Bright does not expect to change its name or trading symbol in conjunction with the consolidation.

How will fractional shares be handled in Therma Bright's consolidation?

Fractions of less than one-half of a share will be cancelled, while fractions of at least one-half of a share will be converted to a whole common share.

Does Therma Bright's share consolidation require shareholder approval?

No, the consolidation was approved by the Board of Directors under the company's Articles of Incorporation, which allows for consolidations up to 10:1 without shareholder approval.
Therma Bright Inc

OTC:TBRIF

TBRIF Rankings

TBRIF Latest News

TBRIF Stock Data

9.70M
422.57M
7.02%
Medical Devices
Healthcare
Link
Canada
Toronto